Covaxin Human Trial
- All
- News
- Videos
-
Covaxin Crosses Half-Way Mark In Phase-3 Trials, Says Bharat Biotech
India's first and only phase III trial of a COVID-19 vaccine has crossed 13,000 subjects - the half-way mark - and proceeding successfully across multiple sites in India, Bharat Biotech, the maker of the inoculant Covaxin, announced today. The trials in the first and second phases had led to promising results.
-
Bharat Biotech's COVID-19 Vaccine 'Covaxin' Commences Phase-3 Trial At AIIMS: Report
Phase-three of human clinical trial of the India-made COVID-19 vaccine candidate Covaxin began at AIIMS in Delhi on Thursday with Dr MV Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.
-
Phase-3 Trial Of Covaxin Begins In Odisha Institute
The third phase human trial of Covaxin, the much-awaited indigenously developed COVID-19 vaccine, has begun at an institute here, a senior official said on Friday.
-
Third Phase Human Trial Of Covid-19 Vaccine To Begin In Bhubaneswar Soon
The third phase of the human trial of the indigenous vaccine against COVID-19, COVAXIN, will commence at a private hospital soon, an official said.
-
In Odisha, Preparation On For 2nd Phase Of Human Clinical Trial Of Covid Vaccine
Preparations are underway at a hospital in Bhubaneswar for the commencement of the second phase of human clinical trial of "Covaxin", India's indigenous COVID-19 vaccine, officials said.
-
Human Clinical Trial Of COVID-19 Vaccine "Covaxin" Begins At UP Hospital
The human clinical trial of indigenously developed Covaxin, a possible vaccine against coronavirus, began at a hospital here, officials said on Friday.
-
Human Trial Of "Covaxin" Begins At SUM Hospital In Bhubaneswar
The human trial of India's first indigenous vaccine candidate "Covaxin" began at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar on Monday.
-
Human Clinical Trial Of Covid Vaccine "Covaxin" Begins At Odisha Hospital
The human clinical trial of indigenously developed Covaxin, a possible vaccine against the novel coronavirus, began at an institute here on Monday, a senior official said.
-
Man, 30, Gets First Dose Of India's Covid Vaccine As Human Trial Begins
A 30-year-old man was on Friday given the first dose of undertrial coronavirus vaccine named as COVAXIN in Delhi's All India Institute Of Medical Sciences.
-
Man Receives First Dose Of Covaxin In Phase-I Of Human Trial At Delhi AIIMS
The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at Delhi AIIMS on Friday and the first dose of the injection was administered to a man who is in his 30s.
-
Covaxin Human Trials: Delhi's Dr Dangs Lab To Partner With Bharat Biotech
A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.
-
Covaxin Human Trials: Delhi's Dr Dangs Lab To Partner With Bharat Biotech
A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.
-
Coronavirus Vaccine Human Trial Begins, Result In 3 Months: AIIMS Head
The human trials of the indigenously developed coronavirus vaccine, COVAXIN, began today, AIIMS-Delhi Director Dr Randeep Guleria said, adding that it would take at least three months for researchers to arrive at the first set of data.
-
AIIMS Panel Allows Human Trial Of India's First Coronavirus Vaccine
The AIIMS Ethics Committee on Saturday gave its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin following which the premier hospital is likely to begin the exercise by enrolling healthy volunteers from Monday.
-
Bharat Biotech Starts Human Trials Of Anti-Covid Vaccine In Haryana
The human trial of India's first anti-COVID vaccine - Covaxin, which is being developed by Bharat Biotech - started at Rohtak's Post-Graduate Institute of Medical Sciences today, Haryana Health and Home Minister Anil Vij said.
-
Covaxin Crosses Half-Way Mark In Phase-3 Trials, Says Bharat Biotech
India's first and only phase III trial of a COVID-19 vaccine has crossed 13,000 subjects - the half-way mark - and proceeding successfully across multiple sites in India, Bharat Biotech, the maker of the inoculant Covaxin, announced today. The trials in the first and second phases had led to promising results.
-
Bharat Biotech's COVID-19 Vaccine 'Covaxin' Commences Phase-3 Trial At AIIMS: Report
Phase-three of human clinical trial of the India-made COVID-19 vaccine candidate Covaxin began at AIIMS in Delhi on Thursday with Dr MV Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.
-
Phase-3 Trial Of Covaxin Begins In Odisha Institute
The third phase human trial of Covaxin, the much-awaited indigenously developed COVID-19 vaccine, has begun at an institute here, a senior official said on Friday.
-
Third Phase Human Trial Of Covid-19 Vaccine To Begin In Bhubaneswar Soon
The third phase of the human trial of the indigenous vaccine against COVID-19, COVAXIN, will commence at a private hospital soon, an official said.
-
In Odisha, Preparation On For 2nd Phase Of Human Clinical Trial Of Covid Vaccine
Preparations are underway at a hospital in Bhubaneswar for the commencement of the second phase of human clinical trial of "Covaxin", India's indigenous COVID-19 vaccine, officials said.
-
Human Clinical Trial Of COVID-19 Vaccine "Covaxin" Begins At UP Hospital
The human clinical trial of indigenously developed Covaxin, a possible vaccine against coronavirus, began at a hospital here, officials said on Friday.
-
Human Trial Of "Covaxin" Begins At SUM Hospital In Bhubaneswar
The human trial of India's first indigenous vaccine candidate "Covaxin" began at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar on Monday.
-
Human Clinical Trial Of Covid Vaccine "Covaxin" Begins At Odisha Hospital
The human clinical trial of indigenously developed Covaxin, a possible vaccine against the novel coronavirus, began at an institute here on Monday, a senior official said.
-
Man, 30, Gets First Dose Of India's Covid Vaccine As Human Trial Begins
A 30-year-old man was on Friday given the first dose of undertrial coronavirus vaccine named as COVAXIN in Delhi's All India Institute Of Medical Sciences.
-
Man Receives First Dose Of Covaxin In Phase-I Of Human Trial At Delhi AIIMS
The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at Delhi AIIMS on Friday and the first dose of the injection was administered to a man who is in his 30s.
-
Covaxin Human Trials: Delhi's Dr Dangs Lab To Partner With Bharat Biotech
A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.
-
Covaxin Human Trials: Delhi's Dr Dangs Lab To Partner With Bharat Biotech
A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.
-
Coronavirus Vaccine Human Trial Begins, Result In 3 Months: AIIMS Head
The human trials of the indigenously developed coronavirus vaccine, COVAXIN, began today, AIIMS-Delhi Director Dr Randeep Guleria said, adding that it would take at least three months for researchers to arrive at the first set of data.
-
AIIMS Panel Allows Human Trial Of India's First Coronavirus Vaccine
The AIIMS Ethics Committee on Saturday gave its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin following which the premier hospital is likely to begin the exercise by enrolling healthy volunteers from Monday.
-
Bharat Biotech Starts Human Trials Of Anti-Covid Vaccine In Haryana
The human trial of India's first anti-COVID vaccine - Covaxin, which is being developed by Bharat Biotech - started at Rohtak's Post-Graduate Institute of Medical Sciences today, Haryana Health and Home Minister Anil Vij said.
